newsfilter
← Latest News
Business Wire·

Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences

  • Arrowhead Pharmaceuticals (NASDAQ: ARWR) announced participation in three upcoming investor events in late 2026.
  • The company will present a Fireside Chat at the 2026 Jefferies Global Healthcare Conference in London on November 18, 2026, at 11:00 am GMT.
  • Arrowhead is scheduled to present a Fireside Chat at Citi's 2026 Global Healthcare Conference on December 2, 2026, at 2:20 pm EST.
  • The company will also present a Fireside Chat at the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026, at 3:00 pm EST.
  • Presentation materials & webcast links will be available on the Events and Presentations page of the Arrowhead Investors section.
  • Arrowhead is a commercial-stage pharmaceutical company developing RNAi therapeutics via its TRiM™ platform to silence genes in various tissues.
  • The press release includes a Safe Harbor Statement regarding forward-looking statements, risks, & uncertainties related to clinical trials, regulatory decisions, & financial performance.
  • Contact information for investors & media inquiries was provided for Vince Anzalone, Paul Graves, Brian Ritchie, & Kendy Guarinoni.